Transcutaneous Oximetry Optimizes Clinical... (2025 study) Skip to main content
Review Undersea Hyperb Med 2025

Transcutaneous Oximetry Optimizes Clinical Management and Cost-Effectiveness of Diabetic Foot Ulcers Treated with Hyperbaric Oxygen: A Review of Point-of-Care Vascular Screening Options

Clarke R, Undersea Hyperb Med, 2025

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The author reviewed ways to check blood flow and oxygen in the skin near diabetic foot ulcers, and argued for which test works best when deciding who should get hyperbaric oxygen therapy.

What They Found

This review article argues that transcutaneous oximetry, a test that measures oxygen levels in tissue, is better than other point-of-care screening tests for guiding hyperbaric oxygen therapy in diabetic foot ulcers. The abstract reports no sample size, trial results or numerical data. It says hyperbaric oxygen has been used for diabetic foot ulcers for more than four decades and is supported by some high-quality evidence, but that conflicting data leave its use open to criticism. The author states that testing with both air and oxygen can show locally reversible hypoxia, and that oximetry can tell responders from non-responders early by detecting new blood vessel growth. The author also states that near-infrared spectroscopy and long-wave infrared thermography do not guide treatment in the same way.

What This Means for Canadian Patients

For people with diabetic foot ulcers, the abstract suggests that better patient selection is a recurring concern when hyperbaric oxygen is considered. It argues that oximetry testing could help decide who continues treatment and when to stop, instead of continuing until the wound closes. These are the author's arguments, not results from a new trial, so patients should talk with their care team about testing and treatment plans.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This is a narrative review that presents the author's argument for one test, reports no new patient data, and acknowledges that evidence for hyperbaric oxygen in diabetic foot ulcers is conflicting.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Review
Category Wound Care
Source Pubmed
PubMed ID 41429030
Year Published 2025
Journal Undersea Hyperb Med
MeSH Terms Humans; Hyperbaric Oxygenation; Diabetic Foot; Cost-Benefit Analysis; Blood Gas Monitoring, Transcutaneous; Oxygen Saturation; Spectroscopy, Near-Infrared; Thermography; Point-of-Care Systems; Patient Selection; Oximetry; Hypoxia

Cite This Study

Share

This study relates to Problem Wounds. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology